UBS Group AG lessened its position in Transcat, Inc. (NASDAQ:TRNS – Free Report) by 18.9% during the 4th quarter, Holdings Channel reports. The firm owned 36,308 shares of the scientific and technical instruments company’s stock after selling 8,480 shares during the quarter. UBS Group AG’s holdings in Transcat were worth $2,060,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in TRNS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Transcat by 6.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock worth $407,000 after buying an additional 325 shares in the last quarter. Jane Street Group LLC acquired a new position in Transcat during the 1st quarter worth about $1,674,000. JPMorgan Chase & Co. lifted its position in Transcat by 88.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 8,555 shares of the scientific and technical instruments company’s stock worth $735,000 after buying an additional 4,012 shares in the last quarter. Legal & General Group Plc lifted its position in Transcat by 6.1% during the 2nd quarter. Legal & General Group Plc now owns 9,551 shares of the scientific and technical instruments company’s stock worth $821,000 after buying an additional 548 shares in the last quarter. Finally, Rhumbline Advisers lifted its position in Transcat by 23.3% during the 2nd quarter. Rhumbline Advisers now owns 16,171 shares of the scientific and technical instruments company’s stock worth $1,390,000 after buying an additional 3,061 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on TRNS. Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a research report on Friday, May 15th. Weiss Ratings reiterated a “sell (d)” rating on shares of Transcat in a research report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Transcat currently has an average rating of “Moderate Buy” and an average target price of $105.33.
Transcat Stock Performance
Shares of NASDAQ:TRNS opened at $78.96 on Friday. The stock has a market capitalization of $736.70 million, a P/E ratio of 136.14 and a beta of 0.68. Transcat, Inc. has a 1-year low of $50.23 and a 1-year high of $91.45. The company has a current ratio of 2.21, a quick ratio of 1.85 and a debt-to-equity ratio of 0.34. The business has a 50-day moving average price of $75.99 and a two-hundred day moving average price of $68.28.
Transcat (NASDAQ:TRNS – Get Free Report) last announced its quarterly earnings data on Tuesday, May 26th. The scientific and technical instruments company reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.05. The firm had revenue of $89.33 million during the quarter, compared to analysts’ expectations of $89.79 million. Transcat had a return on equity of 5.87% and a net margin of 1.62%. Equities analysts predict that Transcat, Inc. will post 1.86 earnings per share for the current year.
Transcat Company Profile
Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.
In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.
Featured Stories
- Five stocks we like better than Transcat
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
